Investing.com – U.S. stocks were higher after the close on Monday, as gains in the Basic Materials, Industrials and Technology sectors led shares higher. At the close in NYSE, the...
Investing.com – U.S. stocks were mixed after the close on Wednesday, as gains in the Technology, Telecoms and Healthcare sectors led shares higher while losses in the Oil & Gas,...
Investing.com – U.S. stocks were higher after the close on Tuesday, as gains in the Industrials, Oil & Gas and Consumer Services sectors led shares higher. At the close in NYSE,...
The first quarter of 2015 has come to a close and companies are still releasing earnings reports. Let’s look back and see which analysts made the best and worst stock...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Strong Sell||Strong Sell||Strong Sell||Strong Sell||Strong Sell|
|Technical Indicators||-||Neutral||Neutral||Neutral||Strong Sell|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Bullish doji Star||1M||2||Dec 18|
|Tri-Star Bullish||1W||7||Dec 02, 2018|
|Dragonfly Doji||1W||9||Nov 18, 2018|
|Stick Sandwich||1W||15||Oct 07, 2018|
|On Neck Bearish||1W||22||Aug 19, 2018|
Egalet Corporation is a specialty pharmaceutical company. The Company is engaged in developing, manufacturing and commercializing treatments for pain and other conditions. The Company's products include OXAYDO and SPRIX Nasal Spray. The Company is developing two late-stage product candidates, ARYMO ER and Egalet-002 using Guardian Technology. The Company's product SPRIX Nasal Spray, which contains ketorolac tromethamine is a non-steroidal anti-inflammatory drug (NSAID) indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level. The Company's product OXAYDO is an approved immediate-release (IR) oxycodone product formulated to deter abuse through snorting. The Company's product candidate, ARYMO ER is an abuse-deterrent (AD), extended-release (ER), oral morphine formulation. The Company's product candidate, Egalet-002, is an abuse-deterrent, extended-release, oral oxycodone formulation.Read More
|Securities Investor Protection Corporation (United States)||$0||Start Trading|
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$500||Start Trading|
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.